Diabetes Mellitus
Definition
Risk Factors
Age over 30y/o
Family history
Ethnic group
Overweight/obese
Lifestyle: sedentary, dietary habits, smoking, alcohol consumption, occupation
Hypertension
Dyslipidaemia
Obstetric history of large babies or gestational diabetes
Women with polycystic ovarian syndrome (PCOS)
Medications that impact weight and glycaemic status
Screening
Who should be screened?
symptomatic
individual who has T2DM symptoms (fatigue, lethargy, polyuria, nocturia, polydipsia, polyphagia, weight loss, pruritus vulvae, balanitis).
asymptomatic
overweight/obese adult (BMI β₯23 kg/m2)
women with history of GDM
all individuals with prediabetes
overweight/obese adolescents with risk factors
More screening criteria based on CPG
Screening tool
Capillary plasma glucose
can be done by using
standard glucometers
no need prior fasting
should be done annually in asymptomatic
Proceed confirmatory test if:
Random: β₯7.8 mmol/L
Fasting: β₯5.6 mmol/L
Diagnostic
Diagnostic test?
symptomatic
- one abnormal glucose value is diagnostic
asymptomatic
- 2 abnormal glucose values are required
1. Fasting plasma glucose
venous plasma glucose
fasting at least 8 hrs
Results
Fasting
(mmol/L)
Random
(mmol/L)
Prediabetes / IFG
6.1 - 6.9
-
Diabetes
β₯7.0
β₯11.1
2. Oral glucose tolerance test (OGTT)
need to fast
using 75 g of glucose
3. HbA1c
symptomatic
- single positive test is sufficient
asymptomatic
- should be done 4 weeks after the first positive test
Pathophysiology
Clinical Features
Symptoms
increased thirst (polydipsia)
polyphagia
polyuria and/or nocturia
malaise/fatigue
History
characteristics at onset (e.g. age, symptoms)
weight loss/gain β some patients may gain weight and develop diabetes e.g. in Cushingβs Syndrome
altered vision
frequent and recurrent infections
risk factors
Physical Examination
Investigations
*investigations for baseline:
Fasting plasma glucose (FPG)
HbA1c
Renal profile
Lipid profile
Liver function test
Urinalysis for albumin, microalbuminuria if albuminuria is absent
ECG
Management
Pharmacological
Drugs & Medications for DM
Target for Glycaemic Control
Fasting or
pre-prandial
4.4 - 7.0 mmol/L
Post-prandial
4.4 - 8.5 mmol/L
HbA1C
<7.0%
Complications
Diabetic Retinopathy
Reference
Interactive Graph
Table Of Contents
Diabetes Mellitus
Definition
Risk Factors
Screening
Who should be screened?
Screening tool
Capillary plasma glucose
Diagnostic
Diagnostic test?
1. Fasting plasma glucose
2. Oral glucose tolerance test (OGTT)
3. HbA1c
Pathophysiology
Clinical Features
Symptoms
History
Physical Examination
Investigations
Management
Pharmacological
Target for Glycaemic Control
Complications
Reference